The emergence of viral escape mutants is usually a highly undesirable phenomenon. This phenomenon is frequently observed in antiviral drug applications for the treatment of viral infections and can undermine long-term therapeutic success. Here, we propose a strategy for evaluating a given antiviral approach in terms of its potential to provoke the appearance of resistant virus mutants. By use of Q RNA phage as a model system, the effect of an antiviral gene therapy, i.e., a virus-specific repressor protein expressed by a recombinant Escherichia coli host, was studied over the course of more than 100 generations. In 13 experiments carried out in parallel, 12 phage populations became resistant and 1 became extinct. Sequence analysis revealed that only two distinct phage mutants emerged in the 12 surviving phage populations. For both escape mutants, sequence variations located in the repressor binding site of the viral genomic RNA, which decrease affinity for the repressor protein, conferred resistance to translational repression. The results clearly suggest the feasibility of the proposed strategy for the evaluation of antiviral approaches in terms of their potential to allow resistant mutants to appear. In addition, the strategy proved to be a valuable tool for observing virus-specific molecular targets under the impact of antiviral drugs.Ideally, antiviral strategies should be highly virus specific and should not affect the host organism. In addition, they should exhibit a minimal potential to allow viral escape mutants to appear. In this paper, we propose a general strategy to evaluate a given antiviral approach with regard to resistance phenomena that may occur due to the emergence of escape mutants. Utilizing RNA phage Q as a model system, we investigated the potential of virus-specific translational repressor proteins to suppress viral propagation. Among the mechanisms that control gene expression, translational regulation is certainly one of the most specific and therefore should be a valuable target mechanism for antiviral strategies.First observed in the RNA phages (29), translational repression has since been discovered in many bacteriophages (47), prokaryotes (11,16,45), and eukaryotes (46) as well as in several mammalian viruses (14,17,35,44). Within the closely related RNA phage species R17, MS2, F2, fr, and Q, two proteins, namely, the coat protein and the replicase, are translational regulators of each other. Shortly after single-stranded viral RNA enters the host cell, replicase protein is translated from the proximal end of the phage genome, leading to high levels of replicated phage RNA.However, it has been shown that replication cannot occur when phage RNA is being translated (25,47). Therefore, strict translational regulation of the remaining cistrons, namely, A1/ coat protein and A2, from the distal portion of the Q RNA genome is essential for the replication. Hence, blocking the translation of the coat protein, which is produced abundantly during the late phase of the viral infection cycl...